EUNETWORKS
6.12.2022 09:46:41 CET | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that its Board of Directors has agreed to the appointment of Paula Cogan as its Chief Executive Officer, effective 1 January 2023. Paula currently holds the position of President, euNetworks. Paula will succeed CEO Brady Rafuse, who will become Chairman of euNetworks’ Board of Directors, with the existing Chairman Neil Hobbs remaining on the Board of Directors as a Non Executive Director.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221206005159/en/
Paula Cogan, euNetworks (Photo: Business Wire)
Paula is currently President, euNetworks, with responsibility for all operating aspects of the business. She joined euNetworks in November 2021, building on her 30 years of working in the telecoms industry. She has held various senior leadership positions in companies such as British Telecom, Verizon and Colt. Prior to joining euNetworks Paula was most recently Executive Vice President – Sales, Marketing and Customer Relationship Management at Colt, responsible for the commercial strategy of the business. Throughout her career Paula has been known for driving transformation in both teams and organisations, leading global sales, marketing, engineering and commercial teams as well as building successful channel strategies. With a strong track record in people management and mentoring, she is committed to promoting and driving inclusion and diversity within the telecoms Industry.
“I am excited to lead this exceptional and high-performing team of people through the next chapter of euNetworks’ growth,” said Paula Cogan. “euNetworks continues to distinguish itself in the digital infrastructure ecosystem, delivering critical internet infrastructure to customers. It’s an asset rich business, focused on developing and deepening its fibre networks, innovating and investing in new technologies to deliver highly scalable, owned and operated fibre-based and sustainable infrastructure in Europe. The vision that Brady and the team have followed and delivered creates an exciting opportunity for us all as we continue to drive the business forward. I want to thank Brady for that and also for his continued support as Chairman as we move forward in 2023.”
Brady joined euNetworks in March 2009. He has led euNetworks through its delisting on the Singapore Stock Exchange, privatisation with Columbia Capital, and sale to Stonepeak, with increased investment from IMCO. The business has become a critical bandwidth infrastructure company supporting Europe’s future bandwidth needs and a portfolio of customers who are the fastest growing consumers of bandwidth under his leadership. Brady has guided the company to become the leading data centre to data centre connectivity provider in Europe, with a unique set of connectivity options in both its metro and long haul network, including the development of Super Highways and new subsea cables. This has enabled the company to deliver exceptional growth and success, underpinned by a team with collective company values and a focus on the belief that bandwidth changes everything.
“I’m immensely proud of the team and it has been a privilege working with them as well as our investors, customers, partners and with the communities that we operate in across Europe,” said Brady Rafuse. “Paula is an exceptional leader. Her achievements in her career have been underpinned by her ability to foster strong relationships with customers and partners whilst remaining focused on leading organisations and people. Paula joined the euNetworks team a year ago and since then we have been working closely to ensure a smooth transition as we move forward with our plans and continue to grow the business. With Paula’s focus over the last year on all operating aspects of the business and her customer-centric approach, she has already made a great contribution to our performance in 2022 and I am excited for the company’s future with Paula as CEO. Thank you to Neil for his support, contribution and guidance since joining the euNetworks Board of Directors in January 2014. His extensive and global board and management experience has been hugely valuable to us all during his time as Chairman on our Board.”
“We know Paula is a fantastic leader and, like Brady, has a clear vision to guide euNetworks as we progress with growth plans for the business,” said Cyrus Gentry, Managing Director and Head of Communications, Europe at Stonepeak. “euNetworks is the fastest growing fibre business in Europe. It has a highly differentiated network platform that underpins the digital infrastructure ecosystem and there remains no shortage of compelling capital opportunities in Europe for euNetworks to further build on the unique position it has in the region. We extend our thanks to Brady for everything he has delivered as CEO, and we look forward to the value he will continue to deliver as Chairman.”
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 490 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.
About Stonepeak
Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $51.7 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, and to have a positive impact on the communities in which it operates. Stonepeak sponsors investment vehicles focused on private equity and credit. The firm provides capital, operational support, and committed partnership to sustainably grow investments in its target sectors, which include communications, energy transition, transport and logistics, and social infrastructure. Stonepeak is headquartered in New York with offices in Austin, Hong Kong, Houston, London and Sydney. For more information, please visit www.stonepeak.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005159/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom